A recent University of Vermont Cancer Center study published in Cancer Epidemiology, Biomarkers & Prevention explores 14 years of screening data and reveals a concerning decline in mammography use across generations. The decline is noteworthy because mammography screening has been credited with helping reduce breast cancer deaths by detecting cancer at earlier, more treatable stages. Even so, breast cancer remains a leading cause of cancer death, second only to lung cancer.
With research from Larner faculty and UVM Cancer Center members—lead author Sarah Nowak, Ph.D., associate professor of pathology and laboratory medicine; Erika Ziller, Ph.D., associate professor of medicine; Michelle Sowden, D.O., professor of surgery; and Brian L. Sprague, Ph.D., professor of surgery at the Larner College of Medicine and co-leader of the UVM Cancer Center’s Population Science and Cancer Outcomes research group—the study highlights the need to better understand factors influencing screening decisions and access to care, which could help guide future efforts to improve breast cancer prevention and early detection in Vermont.
Read the full article about this mammography screening research